Follow us
GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Top Page
About Us
R&D
Investor Relations
Contact Us
[Link to Japanese page]
SNS
トップページ
Top Page
News Release
Release
GNI Announces IND Approval in China for Novel Liver Disease Drug F351
News Release
GNI Announces IND Approval in China for Novel Liver Disease Drug F351
GNI Announces IND Approval in China for Novel Liver Disease Drug F351
GNI Scientists Discovered New Regulatory Mechanism of Key Inflammatory Disease Signalling Pathway
China Patent and Trademark Office Grants Patent for F351,GNI’s Key Therapeutic Product for Liver Disease
News Release
Information
2023
2022
2021
2020
2019
2018
2017
2016
2015
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Event Calendar
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Release
2015
2014
2013
2012
2011
2010
2009
2008
2007
